ICD-10-CM Billable Code

M1A.239

Drug-induced chronic gout, unspecified wrist

Clinical Classification Guidelines

Medical Intelligence & Overview

Drug-induced chronic gout affecting the wrist is a type of long-term joint condition caused by the buildup of uric acid crystals, which is triggered or worsened by certain medications. This condition primarily impacts the wrist, leading to persistent discomfort and joint damage if not properly managed. Chronic gout in this context refers to the ongoing nature of the symptoms, often characterized by recurring flare-ups and joint deformities over time.

Causes & Symptoms

Clinical Causes: Prolonged use of medications that increase uric acid levels, such as diuretics, aspirin, and certain immunosuppressants. Pre-existing conditions that impair uric acid excretion, like kidney disease. Genetic predisposition affecting uric acid metabolism. Lifestyle factors, including high purine diet, alcohol consumption, and obesity, which can compound medication effects. Inadequate management of uric acid levels during therapy with causative drugs.

Key Symptoms: Persistent swelling and tenderness in the wrist joint. Chronic pain that worsens with activity or movement. Formation of tophi, which are nodular deposits of uric acid crystals around the joint. Reduced joint mobility and stiffness, especially in the morning. Possible skin redness and warmth over the affected wrist. Recurrent episodes of acute gout attacks with sudden onset of severe pain, if untreated.

Diagnostic & Treatment

Diagnosis Path: Diagnosis involves a combination of patient history, physical examination, and laboratory tests. Key steps include: - Reviewing medication history to identify potential causative drugs. - Blood tests measuring serum uric acid levels; elevated levels may suggest gout. - Joint aspiration to extract fluid from the wrist, examining it under a microscope for uric acid crystals. - Imaging studies, such as X-rays or ultrasound, to detect joint damage or tophi. - Differentiating drug-induced gout from other forms of arthritis or joint disease.

Treatment Protocols: Managing drug-induced chronic gout generally involves a multidisciplinary approach to reduce uric acid levels, manage symptoms, and modify medication use. Typical strategies include: - Adjusting or discontinuing causative medications under medical guidance. - Using medications such as colchicine, NSAIDs, or corticosteroids to control inflammation and pain during flare-ups. - Implementing urate-lowering therapies like allopurinol or febuxostat to reduce serum uric acid levels over time. - Encouraging lifestyle modifications, including diet changes low in purines, weight management, and limiting alcohol intake. - Regular monitoring of uric acid levels and joint health to prevent progression and recurrent attacks. - Physical therapy or occupational therapy to maintain joint function and reduce stiffness.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is M1A.239 a billable ICD-10 code?
Yes, M1A.239 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report M1A.239?
Clinical documentation must specify the nature of Drug-induced chronic gout, unspecified wrist and any associated comorbidities for accurate reporting.

Cite this Clinical Reference